Skip to main content
Cancers logoLink to Cancers
. 2026 Mar 23;18(6):1033. doi: 10.3390/cancers18061033

Correction: Ahn et al. Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection. Cancers 2025, 17, 1251

Eunyong Ahn 1,, Se Ik Kim 2,, Sungmin Park 1, Sarah Kim 1, Hyunjung Kim 1, Hyejin Lee 1, Heeyeon Kim 3, Eun Ji Song 1, Kyung-Ah Hwang 4, TaeJin Ahn 1,5,*, Yong-Sang Song 6,*
PMCID: PMC13025367  PMID: 41899651

Addition of an Author

Kyung-Ah Hwang was not included as an author in the original publication [1]. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Dr. Kyung-Ah Hwang designed and conducted PCR-based marker identification experiments related to ovarian cancer, participated in primer design and optimization, contributed to data analysis and interpretation, and provided critical intellectual input through manuscript review and revision.

Addition of an Affiliation

Department of Genomic Strategy, Samkwang Labtree, Seoul 06740, Republic of Korea

Conflicts of Interest

Eunyong Ahn, Se Ik Kim, Sungmin Park, Sarah Kim, TaeJin Ahn, and Yong-Sang Song are stockholders of Foretell My Health, Inc. Eunyong Ahn, Sungmin Park, Sarah Kim, Hyunjung Kim, Hyejin Lee, Eun Ji Song, TaeJin Ahn are affiliated with the company Foretell My Health, Inc. Kyung-Ah Hwang is affiliated with the company Samkwang Labtree. We affirm that this conflict of interest does not affect the integrity, objectivity, or validity of the research conducted. All efforts have been made to ensure that the research is conducted impartially and accurately. Patent applications related to some parts of these findings in this study have been filed by the authors.

Author Contributions

E.A., S.I.K., T.A. and Y.-S.S. designed and supervised the research. S.P. and S.K. organize clinical study and lead computational methodology development. S.P. and S.K. performed Bioinformatic analysis. H.L., H.K. (Heeyeon Kim) and H.K. (Hyunjung Kim) performed experiments. S.I.K. and Y.-S.S. recruited patients for clinical research. E.A. wrote the first version of the manuscript. E.J.S. edited the manuscript and wrote the final version of manuscript. K.-A.H. designed and conducted PCR-based marker identification experiments related to ovarian cancer; participated in primer design and optimization; contributed to data analysis and interpretation. All authors have read and agreed to the published version of the manuscript.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Ahn E., Kim S.I., Park S., Kim S., Kim H., Lee H., Kim H., Song E.J., Ahn T., Song Y.-S. Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection. Cancers. 2025;17:1251. doi: 10.3390/cancers17071251. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES